EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy

Sumera Zaib, Nehal Rana iD, Nadia Hussain iD, Hanan A Ogaly iD, Ayed A Dera iD, Imtiaz Khan iD

Molecules · 2023

DOI: 10.3390/molecules28062623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Sumera Zaib und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore 54590, Pakistan. Hauptthemen laut MEDLINE: Alkaptonuria, 4-Hydroxyphenylpyruvate Dioxygenase, Ochronosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alkaptonuria (AKU) is a rare genetic autosomal recessive disorder characterized by elevated serum levels of homogentisic acid (HGA). In this disease, tyrosine metabolism is interrupted because of the alterations in homogentisate dioxygenase (HGD) gene. The patient suffers from ochronosis, fractures, and tendon ruptures. To date, no medicine has been approved for the treatment of AKU. However, physiotherapy and strong painkillers are administered to help mitigate the condition. Recently, nitisinone, an FDA-approved drug for type 1 tyrosinemia, has been given to AKU patients in some countries and has shown encouraging results in reducing the disease progression. However, this drug is not the targeted treatment for AKU, and causes keratopathy. Therefore, the foremost aim of this study is the identification of potent and druggable inhibitors of AKU with no or minimal side effects by targeting 4-hydroxyphenylpyruvate dioxygenase. To achieve our goal, we have performed computational modelling using BioSolveIT suit. The library of ligands for molecular docking was acquired by fragment replacement of reference molecules by ReCore. Subsequently, the hits were screened on the basis of estimated affinities, and their pharmacokinetic properties were evaluated using SwissADME. Afterward, the interactions between target and ligands were investigated using Discovery Studio. Ultimately, compounds c and f were identified as potent inhibitors of 4-hydroxyphenylpyruvate dioxygenase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alkaptonuria4-Hydroxyphenylpyruvate DioxygenaseOchronosisHumansMolecular Docking SimulationHomogentisic Acid

Stichwörter der Autor:innen

4-hydroxyphenylpyruvate dioxygenaseReCorealkaptonuriahomogentisate dioxygenasenitisinone

Substanzen

4-Hydroxyphenylpyruvate DioxygenaseHomogentisic Acid

Autor:innen und Institutionen

  • Department of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab, Lahore 54590, Pakistan.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University, Al Ain P.O. Box 64141, United Arab Emirates.
  • AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi P.O. Box 144534, United Arab Emirates.
  • Chemistry Department, College of Science, King Khalid University, Abha 61421, Saudi Arabia.
  • Biochemistry and Molecular Biology Department, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 62529, Saudi Arabia.

ORCID-Profile: Nehal Rana, Nadia Hussain, Hanan A Ogaly, Ayed A Dera, Imtiaz Khan

Förderung

  • King Khalid University

Zitieren

APA

Zaib, S., Rana, N., Hussain, N., Ogaly, H. A., Dera, A. A., & Khan, I. (2023). Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy. Molecules. https://doi.org/10.3390/molecules28062623

Vancouver

Zaib S, Rana N, Hussain N, Ogaly HA, Dera AA, Khan I. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy. Molecules. 2023. doi:10.3390/molecules28062623

BibTeX
@article{Zaib2023,
  author = {Zaib, Sumera and Rana, Nehal and Hussain, Nadia and Ogaly, Hanan A and Dera, Ayed A and Khan, Imtiaz},
  title = {Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28062623}
}
Kostenlos starten →